In other news, major shareholder Plc Gsk bought 2,791,930 shares of the company’s stock in a transaction on Friday, September ...

Current health news highlights a planned IPO by Medline Industries aiming to exceed $5 billion, a second Australian death from methanol poisoning in Laos, GSK's RSV vaccine approval in Japan, and ...

The GSK (LSE:GSK) share price has fallen off its perch. So it may be a good time to research and consider the stock ...

GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in ...

AnaptysBio’s drug candidates rosnilimab and ANB032 hold key trial results ahead. Find out why ANAB stock is impacted by ...

Samsung Biologics has announced another significant manufacturing agreement, securing a $668m contract with a Europe-based ...

As he introduced Novartis’ meet-the-management event Thursday in London, CEO Vas Narasimhan hammered home Novartis’ status as ...

Recognizing that the available participant population for rare disease studies is often extremely limited and dispersed globally, GSK welcomed an innovative approach to expanding trial access—one that ...

White & Case, Cleary Gottlieb Steen & Hamilton and French firms Gide Loyrette Nouel and Cabinet Bompoint are among the firms ...

The GLP-1 receptor agonist improved both histology and fibrosis in patients, with additional improvements in their liver ...

However, to enhance diversity, companies must adopt a more “youth-ready and youth-friendly approach,” says Matt Lent, chief ...